Search results
Results from the WOW.Com Content Network
In July 2018, the company opened a 200,000 square foot facility in Norwood, Massachusetts for manufacturing, preclinical and clinical work. [24] In December 2018, Moderna became a public company via the largest initial public offering of a biotechnology company in history, raising $621 million by selling 27 million shares at $23 per share. [25 ...
Noubar Afeyan (Western Armenian: Նուպար Աֆէեան; born in 1962) is an American-Canadian entrepreneur, inventor, and philanthropist. [1] [2] He is best known for co-founding the biotechnology company Moderna, through his venture capital firm, Flagship Pioneering, and for co-founding humanitarian projects such as Aurora Prize and The Future Armenian.
In 2014 Rossi retired from his functions at the board and as a scientific advisor at Moderna. [2] In 2015 Rossi was scientific co-founder of Intellia Therapeutics. In 2016 Rossi co-founded Magenta Therapeutics. Rossi was involved in the foundation of Stelexis Therapeutics, which develops new medication for treating cancerous stem cells.
John Abele, co-founder of Boston Scientific, is Vermont's lone billionaire. He lives in Shelburne and a net worth of $1.9 billion, according to Forbes. He lives in Shelburne and a net worth of $1. ...
As vaccine makers are racing to develop updated versions of the vaccine that can tackle the new variants of the coronavirus, Moderna chairman and co-founder Noubar Afeyan joins MSNBC’s Ari ...
(Reuters) - Robert Langer, co-founder and a key figure behind Moderna's scientific success, will step down from the vaccine maker's board on Aug. 5, the company said on Tuesday.
He is the most cited engineer in history [8] and one of the 10 most cited individuals in any field, [9] having authored over 1,500 scientific papers. Langer is also a prolific businessman, having been behind the participation in the founding of over 40 biotechnology companies including the well-known American pharmaceutical company, Moderna.
Before joining Moderna, Bancel was the CEO of French diagnostics company BioMérieux. Bancel is a partner at Flagship Pioneering, and has served on the boards of Indigo Agriculture, Boston's Museum of Science, and Qiagen. As of May 2023, his net worth was estimated at US$4.1 billion, owning about 8% of Moderna. [2]